MedTrace Logo

Pharmacokinetic Profile of Toxic Substances and Nicotine in Electronic Cigarettes

NCT01665066 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 15

Last updated 2012-12-13

No results posted yet for this study

Summary

The aim of the present study is to compare serum nicotine levels of different e-Cigarette strength with usual cigarettes. Serum levels of carcinogenic and toxic substances will be also compared.

Conditions

  • Tobacco Abuse Smoke

Interventions

OTHER

Own Brand cigarette

Smoke, 15 puff of, Own Brand cigarettes;

OTHER

one high 2,4% nicotine

Smoke, 25 puff, of electronic cigarette one high 2,4% nicotine

OTHER

original 7,4 mg nicotine

Smoke, 15 puff, of Categoria electronic cigarette 7,4 mg nicotine

OTHER

nicotine free

smoke, 15 puff, of electronic cigarette nicotine free

OTHER

Ego 9mg

smoke, 15 puff, of electronic cigarette Ego 9 mg

Sponsors & Collaborators

  • Laboratory for Health Protection Research

    collaborator UNKNOWN

  • Universita degli Studi di Catania

    lead OTHER

Principal Investigators

  • Riccardo Polosa, MD, Phd · University of Catania

Study Design

Allocation
RANDOMIZED
Purpose
DIAGNOSTIC
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2012-05-31
Primary Completion
2012-10-31
Completion
2012-10-31

Countries

  • Italy

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01665066 on ClinicalTrials.gov